(Q24241009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

title

Glucocorticosteroids for primary sclerosing cholangitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Vanja Giljaca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Goran Poropat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Davor Stimac

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Vanja Giljaca

1

0 references

publication date

20 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

CD004036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091555%20AND%20SRC:MED&resulttype=core&format=json

Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Therapeutic investigations in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

The management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Primary sclerosing cholangitis: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Bile acids for primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Review article: current management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Recent advances in the management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Small-duct primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Chronic cholestatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Clinical features and management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Current treatments of primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB3

Current concepts. Primary sclerosing cholangitis

21 January 2018

1 reference

12 December 2020

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

12 December 2020

Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination

1 reference

12 December 2020

Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis

1 reference

12 December 2020

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Glucocorticosteroids for primary sclerosing cholangitis

1 reference

12 December 2020

Familial occurrence of primary sclerosing cholangitis and ulcerative colitis

1 reference

12 December 2020

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

12 December 2020

Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study

1 reference

12 December 2020

Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes

1 reference

12 December 2020

The combination of prednisone and colchicine in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

12 December 2020

Primary sclerosing cholangitis: resect, dilate, or transplant?

1 reference

12 December 2020

Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis

1 reference

12 December 2020

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group

1 reference

12 December 2020

Sclerosing cholangitis: broad spectrum of radiographic features

1 reference

12 December 2020